Biofire® Blood Culture Identification 2 (BCID2)
Brand(s)
Last updated
Summary
Product
Biofire® Blood Culture Identification 2 (BCID2)
Issue
Medical devices - Performance
What to do
Contact Biomérieux for additional assistance or questions.
Audience
Healthcare
Affected products
| Affected products | Lot or serial number | Model or catalogue number |
|---|---|---|
| Biofire® Blood Culture Identification 2 (Bcid2) | 2278923 2086722 1611723 2025922 2502223 1785622 2146723 2500523 0798022 2067123 | RFIT-ASY-0147 |
Issue
Biomérieux has identified an increased risk of false positive candida tropicalis results when the Biofire® BCID2 panel is used with the following BD BACTEC™ blood culture vials.
BD BACTEC™ Lytic Anaerobic Medium
BD BACTEC™ Peds Plus Medium
BD BACTEC™ Plus Aerobic Medium
BD BACTEC™ Plus Anaerobic Medium
BD BACTEC™ Standard Aerobic Medium
BD BACTEC™ Standard Anaerobic Medium
Recall start date: February 6, 2024
Additional information
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Medical devices - Chemistry
Companies
| Biofire Diagnostics, Llc. |
| 515 Colorow Dr., Salt Lake City, Utah, United States, 84108 |
Published by
Health Canada
Audience
Healthcare
Recall class
Type II
Identification number
RA-75069
Get notified
Receive notifications for new and updated recalls and alerts by category.